date/time interval
- December 1, 2022 - November 30, 2024
Utilizing EZH2 Inhibition to Improve Immune Therapies in Follicular Lymphoma
Grant
Overview
awarded by
administered by
sponsor award ID
- FLF 224362-01
Affiliation
contributor
- Beguelin, Wendy Principal Investigator 2022 - 2024
- Melnick, Ari M. Key Personnel 2022 - 2024